Quanticate announces strategic partnership with KPS Life
James Spargo | June 5, 2023 | News story | Medical Communications | KPS Life, Pharmacy, Quanticate, fsp
Global biometric clinical research group Quanticate has announced a strategic partnership with US-based provider of functional service provision (FSP) solutions KPS Life.
Quanticate will bring expert biometric data services to combine with KPS Life’s global resourcing solutions, enabling both organisations to provide life sciences companies with an end-to-end solution that delivers high quality data and human capital solutions.
David Underwood, CEO of Quanticate, stated: “We are thrilled to be partnering with KPS Life and offering biotech and pharma companies access to our expert biometric data services alongside KPS Life’s FSP solutions. By combining our expertise, we will be able to provide an end-to-end solution that delivers high-quality data and comprehensive clinical services to sponsors. This partnership represents a significant milestone for Quanticate and KPS Life, and we look forward to working together to deliver exceptional results for our clients.”
David Kelly, CEO of KPS Life, commented: “Our clients have come to expect high quality resource solutions and our deep commitment to solving their staffing challenges in this tough labour environment. We are confident that partnering with Quanticate will be a strong addition to our collective service offerings. This partnership represents an exciting opportunity for sponsor companies to access a full range of services from two expert organisations. We believe our collaboration will help companies achieve their clinical research goals more efficiently and effectively.”
James Spargo
Related Content
Chiltern acquires Ockham to help lift status
Chiltern has today acquired a full stake in fellow contract research organisation Ockham as both …
Contract research news in brief
A round-up of recent developments in the contract research sector, including KKR’s acquisition of PRA, …
Contract research news in brief
ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, …
